Načítá se...
Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens
Attenuated vaccinia virus (VACV) vectors are considered prime vaccine candidates for use in immunotherapy of infectious disease. In spite of this, recent data show that the level of attenuation may hamper the efficient generation of protective CD8 T cells. This suggests that additional adjuvant-like...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3492829/ https://ncbi.nlm.nih.gov/pubmed/23162550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2012.00332 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|